Skip to main content
AbClon Inc. logo

AbClon Inc. — Investor Relations & Filings

Ticker · 174900 ISIN · KR7174900001 KO Manufacturing
Open in API
Filings indexed 254 across all filing types
Latest filing 2022-05-10 Regulatory Filings
Country KR South Korea
Listing KO 174900

About AbClon Inc.

https://www.abclon.com/en/

AbClon Inc. is a clinical-stage company focused on the research and development of antibody-based therapeutics. The company leverages three core proprietary platforms. The CAR-T platform develops personalized cell therapies for cancer patients by engineering a patient's own immune cells to target and destroy cancer cells, with a focus on blood cancers. The NEST (Novel Epitope Screening Technology) platform is designed to discover antibodies that target unique, previously unaddressed sites on disease proteins, enabling novel therapeutic effects. The AffiMab platform facilitates the development of bispecific antibodies that can simultaneously engage two different disease targets, aiming to maximize therapeutic efficacy in refractory diseases.

Recent filings

Filing Released Lang Actions
기타경영사항(자율공시)(국책과제선정(혁신 CD19 표적 CAR-T 치료제 임상 1상 연구))
Regulatory Filings Classification · 100% confidence The document is a voluntary disclosure ('자율공시') from AbClon regarding the selection of a national research project for a CAR-T clinical trial. It details the project scope, funding, and expected outcomes. Since it does not fit into specific categories like financial reports, M&A, or director dealings, and serves as a general regulatory announcement of a business development, it is classified as a Regulatory Filing (RNS).
2022-05-10 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties, including stock option grants. This falls under the category of 'Major Shareholding Notification' (MRQ).
2022-04-01 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results from a General Meeting of Shareholders (Annual General Meeting). It details the outcomes of voting on agenda items such as financial statement approval, director appointments, and remuneration limits. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2022-03-29 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to executives and employees, including the number of shares, exercise price, and vesting conditions. This type of disclosure regarding capital structure changes and employee compensation via stock options falls under the category of 'Share Issue/Capital Change' (SHA) as it relates to the issuance of new shares and changes in equity structure.
2022-03-29 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to executives and employees, including the number of shares, exercise price, and vesting conditions. This type of disclosure regarding capital structure changes and employee compensation via stock options falls under the category of 'Share Issue/Capital Change' (SHA) as it relates to the issuance of new shares and changes in equity structure.
2022-03-29 Korean
[기재정정]주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) issued by AbClon Inc. It includes details about the meeting date, location, agenda items (such as financial statement approval, director appointments, and stock option grants), and management reference materials. This is a standard proxy statement/notice document sent to shareholders to inform them of an upcoming meeting and solicit their participation/votes. In the context of the provided categories, this fits best as a Proxy Solicitation & Information Statement.
2022-03-23 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.